Diagnostic Failure in Invasive Fungal Infections: Causes, Clinical Consequences, and Mitigation Strategies

Pilar Rivas-Pinedo1, José Millán Oñate Gutiérrez2,3,4

  • 1Medical and Diagnostic Mycology Group, Department of Microbiology, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia.

Insights

Diagnostic failure in invasive fungal infections (IFIs) leads to poor outcomes. A new framework, AFSP-Dx, aims to improve early recognition and treatment through better diagnostics and stewardship.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Diagnostic Microbiology

Background:

  • Diagnostic failure in invasive fungal infections (IFIs) is a significant cause of mortality and morbidity.
  • Despite advances in diagnostic tools, timely diagnosis remains challenging due to complex interactions between host, pathogen, and healthcare systems.

Purpose of the Study:

  • To analyze diagnostic failure in IFIs as a dynamic process, examining its determinants and consequences.
  • To propose a diagnostic-centered antifungal stewardship framework (AFSP-Dx) to improve diagnostic accuracy and therapeutic decisions.

Main Methods:

  • Narrative review of diagnostic failure in IFIs across various high-risk populations and fungal pathogens.
  • Analysis of factors contributing to diagnostic failure, including delayed sampling and fragmented team communication.
  • Development of the AFSP-Dx framework incorporating syndromic bundles and population-specific algorithms.

Main Results:

  • Diagnostic failure encompasses delayed, incorrect, and incomplete diagnoses, impacting critically ill patients, transplant recipients, and neonates.
  • Specific IFIs like candidiasis, aspergillosis, and mucormycosis are frequently affected by diagnostic delays.
  • Incomplete microbiological identification and lack of susceptibility testing exacerbate adverse outcomes.

Conclusions:

  • The AFSP-Dx framework offers a structured approach to enhance early recognition and precise treatment of IFIs.
  • Implementing auditable indicators and population-specific algorithms can rationalize antifungal use and improve patient care.
  • Addressing diagnostic fragmentation and improving laboratory-clinical collaboration are crucial for mitigating IFI-related mortality.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...